Billion Reason Tech ETFs Spark Market Reallocation
Tech ETFs split into three paths in 2026: broad mega-cap funds stumble, cybersecurity themes gain ground, and AI infr...
What Affects Stock Index Levels
Index levels move with price changes, weighting shifts, and market events. This overview highlights the main drivers behind index fluctuations.
20,883 articles
This Power Player Owns XRP ETFs: Should You Buy It Today?
A high-profile investor recently revealed a sizable XRP ETF stake. This article breaks down what that means, how XRP ...
Analyst Thinks ASML Worth Nearly $2K on EUV Rally Today
A major brokerage lifts its price target for ASML to near $2,000, citing surging EUV demand from DRAM makers and a sw...
Morgan Stanley Slashes Lucid Target in Half Amid Stop-Sale
Morgan Stanley halves Lucid's price target to $5, keeping an Underweight rating as production stoppages and a leaders...
Midland Wealth Advisors Initiates Bluerock Real Estate Stake
A recent SEC 13F shows Midland Wealth Advisors initiating a stake in Bluerock Private Real Estate Fund. Learn why thi...
Broadcom's Future $100 Billion Chip Drive: Buy Now
Broadcom is shifting from a broad tech portfolio to a focused AI chip powerhouse. If the company can turn custom AI c...
NVIDIA Hits $5.5 Trillion Market Cap, Surging Ahead
NVIDIA breached a $5.5 trillion market cap, marking a historic leap for a chipmaker tied to AI. The move highlights t...
Price Prediction: CVS Eyes Upside After Q1 Surge, Strong
CVS Health posts a robust Q1 driven by Aetna, lifting guidance and reigniting investor optimism. The market now weigh...
Prediction: This Will Next Trillion-Dollar Company to Watch
The trillion-dollar club is expanding, and a few ahead-of-the-curve signals can help you spot the next member. This g...
Elon Musk Ditch California Sparks SpaceX IPO Hopes Rise
SpaceX is weighing a high-profile IPO that could bring California a much-needed economic boost despite the chatter ar...
Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Two Distinct Growth Paths: Johnson & Johnson vs AbbVie
Johnson & Johnson and AbbVie report strong Q1 2026 results, showcasing two contrasting growth paths as biosimilar cha...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status